Open trial of methotrexate as treatment for autoimmune hearing loss
Eric L. Matteson(Mayo Clinic), Thomas J. McDonald(Texas A&M Health Science Center), George W. Facer(Mayo Clinic), Colin L. W. Driscoll(Mayo Clinic), David A. Fabry(Mayo Clinic), Charles W. Beatty(Mayo Clinic), Scott E. Strome(Northwestern Medicine Lake Forest Hospital)
Cited by 5
Related Papers
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|Arthritis & Rheumatism|2012|6.6k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis & Rheumatology|2015|2.8k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|UNC Libraries|2020|1.3k